- Latest available (Revised)
- Original (As made)
This is the original version (as it was originally made).
3. Subject to article 6, the following descriptions and classes of medicinal products are specified for the purposes of section 58, namely–
(a)medicinal products consisting of or containing a substance listed in column 1 of Schedule 1;
(b)medicinal products that are controlled drugs;
(c)medicinal products that are for parenteral administration, other than preparations of insulin for parenteral administration;
(d)cyanogenetic substances, other than preparations for external use;
(e)medicinal products that on administration emit radiation, or contain or generate any substance which emits radiation, in order that radiation may be used;
(f)medicinal products for human use which are classified as subject to medical prescription in marketing authorizations granted under Council Regulation 2309/93(1);
(g)medicinal products–
(i)which are not of a description and do not fall within a class specified in subparagraphs (a) to (f),
(ii)which are of a description in respect of which the conditions specified in section 59(1) are satisfied, and
(iii)in respect of which a product licence or marketing authorization has been granted which contains a provision to the effect that the method of sale or supply of the medicinal product is to be only in accordance with a prescription given by an appropriate practitioner.
OJ No. L214, 24.8.93, p. 1.
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: